Overall Technical outlook

Price Summary

On 2025-12-15, TORNTPHARM's stock opened at 3791.8, reached a peak of 3809.9, dropped to 3752.5, and ended -0.24% lower at 3782.6, with a volume of 168484 shares.
In the last 52 weeks, the stock's top price was 3831.8 and the bottom price was 2930.3.
26 analysts forecast that the price of TORNTPHARM will range from 3530.0 to 4380.0, with an average expected price near 4024.2693.

Technicals

Support and Resistance: With the current price at 3782.6, support is found at 3730.6 and resistance at 3825.8. These levels indicate where buyers might step in at 3730.6, while sellers could limit gains at 3825.8, defining a trading boundary for Torrent Pharmaceuticals Limited.
TORNTPHARM supportResistance 4c4d44
Support/Resistance for TORNTPHARM


Aroon: The AROON is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
TORNTPHARM aroon 4c4d44
Aroon chart for Torrent Pharmaceuticals Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
TORNTPHARM bbands 4c4d44
Bolinger Bands chart for Torrent Pharmaceuticals Limited


Parabolic SAR: The PSAR for TORNTPHARM continues to indicate a bearish outlook, reinforcing a resistance level that could limit upward potential. This suggests that the market may remain under bearish control, with resistance acting as a barrier to significant upward movement.
TORNTPHARM psar 4c4d44
Parabolic Stop and Reverse chart for Torrent Pharmaceuticals Limited


Stochastic: The STOCHASTIC is in a neutral stance for TORNTPHARM, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
TORNTPHARM stoch 4c4d44
Stochastic chart for Torrent Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
TORNTPHARM trippleSMA 4c4d44
Tripple SMA chart for Torrent Pharmaceuticals Limited


In order to draw meaningful inferences from a company's technical data, it is essential to first consider its fundamentals. This includes reviewing financial metrics like revenue, profit margins, and debt-to-equity ratios. Additionally, understanding the broader industry landscape, including market trends and competitive pressures, is crucial. By integrating these insights with the company's technical performance, such as stock price fluctuations and trading volume, one can make more informed investment decisions.